Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

PURE BIOSCIENCE, INC. PURE

· Materials · Miscellaneous Chemical Products

FY2025 10-K, filed 2025-10-29
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 4/5 core metrics

Latest reported free cash flow was -$3M.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Free cash flow was negative

    Latest reported free cash flow was -$3M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2023-07-31.

  • Shareholders' equity was non-positive

    Debt/equity is shown as not meaningful rather than as a negative leverage ratio.

    Why this surfaced

    Same-period reported shareholders' equity was zero or negative; review the balance sheet and capital structure. Period end 2025-07-31.

  • 5 filing risk checks flagged

    Flagged areas: Earnings quality, Solvency & liquidity, Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue expanded

    Latest reported annual revenue changed +12.2% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-07-31.

  • Operating margin improved

    Operating margin changed +59.4 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-07-31.

Core trend metrics

Latest annual revenue growth
+12.2%
as of 2025-07-31
Latest annual operating margin
-103.2%
as of 2025-07-31
Free cash flow
-$3M
as of 2023-07-31
Debt / equity
N/M
as of 2025-07-31

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

5of 11 rule-based checks flagged
  • Earnings quality
  • Solvency & liquidity
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-07-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-07-3110-K filed 2025-10-29prior period 2024-07-31 from the same filingView filing
By product or service
Revenue
  • PURE Hard Surface$2M
    90.8%
    +7.4% yoy
  • Sil Verion$203K
    9.2%
    +109.3% yoy

Members sum to the consolidated $2.2M for this period.

Latest quarter
Quarter ending 2026-04-3010-Q filed 2026-06-15prior period 2025-04-30 from the same filingView filing
  • Sil Verion$414K
    81.8%
    +1871.4% yoy
  • PURE Hard Surface$92K
    18.2%
    -80.3% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

Not available for PURE: No stored feature row with a computable metric for this issuer (funds, trusts and 20-F filers are not crawled)..

Earnings quality

Not available for PURE yet: Earnings-quality fields arrive with this issuer's next re-crawl (sec_screen_v6)..

Point-in-time ledger

Not available for PURE yet: The point-in-time ledger arrives with this issuer's next re-crawl (sec_screen_v6)..

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest quarterly report10-Q FY2026 Q3 · filed 20260615View filing
Debt · 7,117 characters as filed

5. Convertible Notes Payable to Related Parties Schedule of Convertible Notes Maturity Interest Rate April 30, 2026 July 31, 2025 Fiscal 2023 Notes (a) June 2026 7.55 % $ 1,015,000 $ 1,015,000 Fiscal 2023 Notes (a) June 2026 7.55 % $ 1,015,000 $ 1,015,000 Fiscal 2024 Notes (b) October 2026 to June 2027 7.81 % 1,785,000 1,785,000 Fiscal 2025 Notes (c) September 2027 to July 2028 6.79 %- 7.88 % 2,000,000 2,000,000 Fiscal 2026 Notes (d) October to February 2029 6.16 % - 6.68 % 970,000 5,770,000 4,800,000 Accrued interest 727,000 436,000 Total $ 6,497,000 $ 5,236,000 (a) In fiscal 2023, the Company entered into a Note Purchase Agreement (the 2023 Note Purchase Agreement) with certain accredited investors (Lenders) pursuant to which the Company issued the Lenders convertible promissory notes with an aggregate principal balance of $ 1,015,000 (the 2023 Private Placement). Messrs. Tom Y. Lee and Ivan Chen, each a member of the Companys Board invested $ 1,000,000 and $ 15,000 , respectively in the 2023 Private Placement, through affiliates or directly. As of April 30, 2026, $ 1,015,000 of principal was outstanding under the 2023 Private Placement, which amount is currently due. (b) In fiscal 2024, the Company entered into a Note Purchase Agreement (the 2024 Note Purchase Agreement) with certain accredited investors (Lenders) pursuant to which the Company issued the Lenders convertible promissory notes with an aggregate principal balance of $ 1,785,000 (the 2024 Private Placement). To

DebtDisclosureTextBlock · excerpt; the full note is in the filing

Related parties · 180 characters as filed

8. Related Party Transactions As of April 30, 2026 and April 30, 2025, accounts payable include $ 235,000 and $ 249,000 , respectively, in board fees due to officers and directors.

RelatedPartyTransactionsDisclosureTextBlock

Significant accounting policies · 11,583 characters as filed

3. Significant Accounting Policies Revenue Recognition The Company recognizes revenue in accordance with the Financial Accounting Standards Board or the FASB, Accounting Standards Codification or ASC, Topic 606, Revenue from Contracts with Customers or Topic 606. Under Topic 606, revenue is recognized at an amount that reflects the consideration to which it expects to be entitled in exchange for transferring goods or services to a customer. This principle is applied using the following 5-step process: 1. Identify the contract with the customer 2. Identify the performance obligations in the contract 3. Determine the transaction price 4. Allocate the transaction price to the performance obligations in the contract 5. Recognize revenue when (or as) each performance obligation is satisfied Under Topic 606, the Company recognizes revenue when it satisfies a performance obligation by transferring control of the promised goods or services to its customers, in an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Companys technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers residual protection and formulates well with other compounds. The Company sells various configurations and dilutions of SDC direct to customers and through distributors. The Company currently offers PURE H

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

Stockholders' equity · 4,796 characters as filed

7. Stockholders Equity Restricted Stock Units The Company issues restricted stock unit awards, or RSUs, to key management and as compensation for services to consultants and others. The RSUs typically vest over a one 1 to three 3 -year period and carry a ten 10 -year term. Each RSU represents the right to receive one share of common stock, issuable at the time the RSU subsequently settles, as set forth in the Restricted Stock Unit Agreement. The Company determines that fair value of those awards at the date of grant, and amortize those awards as an expense over the vesting period of the award. The shares earned under the grant are usually issued when the award settles at the end of the term. As of April 30, 2026, all the RSUs had vested and 712,500 RSUs are issuable as of April 30, 2026. During the nine months ended April 30, 2025, the Company granted 30,000 RSUs to a third-party consultant for manufacturing services. The RSUs vested 100% on the date of grant. As a result, the Company recognized the entire fair value of $ 3,000 of compensation cost relating to the vesting of the RSUs. Stock Option Plans 2024 Equity Incentive Plan The Companys shareholders approved its 2024 Equity Incentive Plan, or the 2024 Plan, in February 2024, which has a share reserve of 10,000,000 shares of common stock that were registered under a Form S-8 filed with the SEC in August 2024. The 2024 Plan provides for the grant of incentive and non-qualified stock options, as well as other share-based p

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

Subsequent events · 335 characters as filed

9. Subsequent Events The Companys stockholders approved an amendment to the Companys Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 shares to 250,000,000 shares. The amendment became effective upon filing with the Secretary of State of the State of Delaware on May 27, 2026.

SubsequentEventsTextBlock · excerpt; the full note is in the filing

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.